Predictors of depression in women with polycystic ovary syndrome

Archives of Women's Mental Health

Volumn 18, Issue 1, 2015, Pages 95-101

  Naqvi, Syed Haider ^a   Moore, Ava ^a   Bevilacqua, Kris ^b   Lathief, Sanam ^c   Williams, Joanne ^d   Naqvi, Nighat ^d   Pal, Lubna ^d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b IVF Laboratory   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25OHD; Depression; PHQ; Polycystic ovary syndrome; Vitamin D

Indexed keywords

VITAMIN D; 25 HYDROXYERGOCALCIFEROL;

ACNE; ADULT; ARTICLE; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; NIGHT SLEEP; NUTRITIONAL STATUS; OVARY POLYCYSTIC DISEASE; PATIENT HEALTH QUESTIONNAIRE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITAMIN D DEFICIENCY; ADOLESCENT; BLOOD; BODY MASS; COMPLICATION; METABOLISM; MULTIVARIATE ANALYSIS; POLYCYSTIC OVARY SYNDROME; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

25-HYDROXYVITAMIN D 2; ADOLESCENT; ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIRSUTISM; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84921903438     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-014-0458-z     Document Type: Article

References (23)

1. Azziz R, Woods KS, Reyna R, Key TJ et al (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749
2. Catherine Marin DU, Woods KS, Alfred A, Bartolucci, Ricardo A (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345–1350
3. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L (2005) A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 152(5):986–992
4. Dokras A (2012) Mood and anxiety disorders in women with PCOS. Steroids 77(4):338–341
5. Drosdzol A, Skrzypulec V, Plinta R (2010) Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 31(3):168–175
6. Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES (2011) Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 86(11):1050–1055
7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930
8. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. Wiley, New York
9. Jaussent I, Bouyer J, Ancelin ML, Akbaraly T, Pérès K, Ritchie K, Besset A, Dauvilliers Y (2011) Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep 34(8):1103–1110
10. Jaworska N, Thompson A, Shah D, Fisher D, Ilivitsky V, Knott V (2012) Acute tryptophan depletion effects on the vertex and late positive potentials to emotional faces in individuals with a family history of depression. Neuropsychobiology 65(1):28–40
11. Kao CC, Huang CJ, Wang MY, Tsai PS (2008) Insomnia: prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population. Qual Life Res 17(8):1073–1080
12. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92(3):1053–1058
13. Kroenke K, Spitzer RL, Williams JB, Löwe B (2010) The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 32(4):345–359, Review
14. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K et al (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270
15. Norman A (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. In: The American Journal of Clinical Nutrition, 491S–9S
16. Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J et al (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28(12):965–968
17. Parish J (2009) Sleep-related problems in common medical conditions. Chest 135(2):563–572
18. Rashidi B, Haghollahi F, Shariat M, Zayerii F (2009) The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 48(2):142–147
19. Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84, Review
20. Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011) An update on the presence of psychiatric comorbidities in acne patients, Part 2: depression, anxiety, and suicide. Cutis 88(2):92–97
21. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S (2010) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33(4):234–238
22. Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41
23. Wehr E, Schweighofer N, Giuliani A, et al. (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. In: European Journal of Endocrinology, 575–582